BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 10365678)

  • 1. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny.
    Minich WB; Weymayer JD; Loos U
    Exp Clin Endocrinol Diabetes; 1999; 107(8):555-60. PubMed ID: 10612487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
    Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and discrimination of autoimmune Graves' disease and Hashimoto's disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes.
    Fukushima H; Matsuo H; Imamura K; Morino K; Okumura K; Tsumoto K; Yoshimura T
    J Biosci Bioeng; 2009 Dec; 108(6):551-6. PubMed ID: 19914592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On specificity of 2nd generation TSH receptor autoantibody measurements.
    Zöphel K; Grüning T; Roggenbuck D; Wunderlich G; Kotzerke J
    Clin Lab; 2008; 54(7-8):243-9. PubMed ID: 18942492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
    Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
    J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin receptor autoantibodies in Graves' disease.
    Schott M; Scherbaum WA; Morgenthaler NG
    Trends Endocrinol Metab; 2005 Jul; 16(5):243-8. PubMed ID: 15950483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
    Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
    Rapoport B; Aliesky HA; Chen CR; McLachlan SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies.
    Morgenthaler NG; Tremble J; Huang G; Scherbaum WA; McGregor AM; Banga JP
    J Clin Endocrinol Metab; 1996 Feb; 81(2):700-6. PubMed ID: 8636291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
    Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
    J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
    Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
    J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
    McLachlan SM; Aliesky HA; Rapoport B
    Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.